'Revertant' DCIS in human axillary breast carcinoma metastases

Journal of Pathology

Volumn 183, Issue 2, 1997, Pages 188-194

  Barsky, Sanford H ^a   Doberneck, Susan A ^a   Sternlicht, Mark D ^a   Grossman, Deborah A ^a   Love, Susan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autochthonous metastasis; Basement membrane; Breast carcinoma; DCIS; Myoepithelial cells

Indexed keywords

ACTIN; COLLAGEN TYPE 4; ESTROGEN RECEPTOR; LAMININ; PROTEIN S 100;

ARTICLE; AXILLARY LYMPH NODE; BASEMENT MEMBRANE; BREAST CARCINOMA; CANCER GROWTH; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MYOEPITHELIUM CELL; PHENOTYPE; PRIORITY JOURNAL;

AXILLA; BASEMENT MEMBRANE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CELL DIFFERENTIATION; CELL NUCLEUS; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPHATIC METASTASIS;

EID: 0030768934     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199710)183:2<188::AID-PATH898>3.0.CO;2-7     Document Type: Article

References (30)

1. Safarians S, Sternlicht MD, Freiman CJ, Huaman JA, Barsky SH. The primary tumor is the primary source of metastasis in a human melanoma/ Scid model. Implications for the direct autocrine and paracrine epigenetic regulation of the metastatic process. Int J Cancer 1996; 66: 151-158.
2. Stephenson RA, Dinney CPN, Gohji K, Ordonez NG, Killion IJ, Fidler IJ. Metastatic model for human prostate cancer using orthotropic implantation in nude mice. J Natl Cancer Inst 1992; 84: 951-956.
3. Weiss L. Metastatic inefficiency. Adv Cancer Res 1990; 54: 159-211.
4. Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994; 11: 167-180.
5. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995; 345: 1154-1157.
6. Fu YS, Cheng L, Huang L, DNA ploidy analysis of cervical condyloma and intraepithelial neoplasia in specimens obtained by punch biopsy. Anal Quant Cytol Histol 1989; 11: 187-195.
7. Barsky SH, Siegal GP, Jannotta F, Liotta LA. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 1983; 49: 140-148.
8. Cossman J, Schlegal R. p53 in the diagnosis of human neoplasia. J Natl Cancer Inst 1991; 18: 980-981.
9. Visakorpi T, Kallioniemi OP, Koivula T, Harvey J, Isola J. Expression of epidermal growth factor receptor and ERB2 (Her-2/neu) oncoprotein in prostatic carcinomas. Mod Pathol 1992; 5: 643-648.
10. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357-363.
11. Allred D, Clark G, Molina R, et al. Overexpression of Her-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol 1992; 23: 974-979.
12. Cheng L, Binder S, Fu Y, Lewin K. Demonstration of estrogen receptors by monoclonal antibody in formalin-fixed breast tumors. Lab Invest 1988; 58: 346-353.
13. Greene G, Nolan C, Engler J, Jensen E. Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci USA 1990; 77: 5115-5119.
14. Shana-Rong S, Key ME, Kalra KL. Antigen retrieval in formalin-fixed paraffin-embedded tissues: an enhancement method of immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741-748.
15. Barsky SH, Lay-field L, Varki N, Bhuta S. Two human tumors with high basement membrane-producing potential. Cancer 1988; 61: 1798-1806.
16. Sternlicht MD, Safarians S, Rivera SP, Barsky SH. Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors. Lab Invest 1996; 74: 781-796.
17. Zou Z, Anisowicz A, Hendrix MJC, et al. Maspin, a serpin with tumorsuppressing activity in human mammary epithelial cells. Science 1994; 263: 526-529.
18. Kohn EC, Liotta LA, Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995; 55: 1856-1862.
19. Liotta L, Steeg P, Stetler-Stevenson W. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-336.
20. Zhuang Z, Merino MJ, Chuaqui R, Liotta LA, Emmert-Buck MR. Identical allelic loss on chromosome I1q13 in microdissected in situ and invasive human breast cancer. Cancer Res 1995; 55: 467-471.
21. Page D, Dupont W, Rogers L, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 1982; 49: 751-758.
22. Rosen P, Braun D, Kinne D. The clinical significance of pre-invasive breast carcinoma. Cancer 1980; 46: 919-925.
23. Sternlicht MD, Safarians S, Calcaterra TC, Barsky SH. Establishment and characterization of a novel human myoepithelial cell line and matrix producing xenograft from a parotid basal cell adenocarcinoma. In Vitro Cell Dev Biol 1996; 32: 550-563.
24. Laeios MD, Westdahl PR,. Margolin FR, Rose MR. Duct carcinoma in situ. Cancer 1982; 50: 1309-1314.
25. Gusterson BA, Warburton MJ, Mitchell D, Kraft N, Hancock WW. Invading squamous cell carcinoma can retain a basal lamina. Lab Invest 1984; 51: 82-87.
26. Sirtori C, Talamazzi F. Il carcinoma intraduttale della mammella non e'mai un carcinoma in situ. Tumori 1967; 53: 641-644.
27. Van de Vijver M, Peterse J, Mooi W, et al. Neu-protein Overexpression in breast cancer. N Engl J Med 1988; 319: 1239-1245.
28. Meyer JS, Cell kinetics of histologic variants of in situ breast carcinoma Breast Cancer Res Treat 1986; 7: 171-180.
29. Leygue E, Snell L, Hiller T. et al. Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res 1996; 56: 4606-4609.
30. Sharkey FE, Greiner AS. Morphologic identity of primary tumor and axillary metastases in breast carcinoma. Arch Pathol Lab Med 1985; 109: 256-259.